![]() |
|
|
Vol. 53, Issue 5, 902-907, May 1998
Section of Molecular and Cellular Cardiology, Department of
Medicine, The Johns Hopkins University School of Medicine, Baltimore,
Maryland 21205
Dihydropyridines (DHPs) block L-type Ca2+ channels more
potently at depolarized membrane potentials, consistent with high
affinity binding to the inactivated state. Nisoldipine (a DHP
antagonist) blocks the smooth muscle channel more potently than the
cardiac one, a phenomenon observed not only in native channels but also in expressed channels. We examined whether this tissue specificity was
attributable to differences of inactivation in the two channel types.
We expressed cardiac or smooth muscle
1C subunits in combination with
2a and
2/
subunits in human embryonic kidney cells, and used 2 mM Ca2+ as the permeant ion. This system
thus reproduces the in vivo topology and charge carrier
of the channels while facilitating comparison of the two
1C splice
variants. Both voltage-dependent and isoform-specific sensitivity of 10 nM nisoldipine inhibition of the channel were demonstrated,
with the use of
100 mV as the holding potential for fully reprimed
channels and
65 mV to populate the inactivated state. Under drug-free
conditions, we characterized fast inactivation (1-sec prepulses) and
slow inactivation (3 min prepulses) in the two isoforms. Inactivation
parameters were not statistically different in the two channel
isoforms; if anything, cardiac channels tended to inactivate more than
the smooth muscle channels at relevant voltages. Likewise, the
voltage-dependent activation was identical in the two isoforms. We thus
conclude that the more potent nisoldipine inhibition of smooth muscle
versus cardiac L-type Ca2+ channels is not attributable to
differences in channel inactivation or activation. Intrinsic,
gating-independent DHP receptor binding affinity differences must be
invoked to explain the isoform-specific sensitivity of the DHP block.
This article has been cited by other articles:
![]() |
P. Liao, D. Yu, G. Li, T. F. Yong, J. L. Soon, Y. L. Chua, and T. W. Soong A Smooth Muscle Cav1.2 Calcium Channel Splice Variant Underlies Hyperpolarized Window Current and Enhanced State-dependent Inhibition by Nifedipine J. Biol. Chem., November 30, 2007; 282(48): 35133 - 35142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tiwari, Y. Zhang, J. Heller, D. R. Abernethy, and N. M. Soldatov Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel {alpha}1C subunit PNAS, November 7, 2006; 103(45): 17024 - 17029. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liao, T. F. Yong, M. C. Liang, D. T. Yue, and T. W. Soong Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles Cardiovasc Res, November 1, 2005; 68(2): 197 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pignier and D. Potreau Characterization of nifedipine-resistant calcium current in neonatal rat ventricular cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2259 - H2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berjukow, R. Marksteiner, F. Gapp, M. J. Sinnegger, and S. Hering Molecular Mechanism of Calcium Channel Block by Isradipine. ROLE OF A DRUG-INDUCED INACTIVATED CHANNEL CONFORMATION J. Biol. Chem., July 14, 2000; 275(29): 22114 - 22120. [Abstract] [Full Text] [PDF] |
||||